1. Medtech Insight

Lab Group Urges FDA To Wait For Congress On LDT Issue

Jeff Shuren recently spoke at the annual American Clinical Laboratory Association industry meeting where the device center director was grilled on FDA's plans to regulate lab-developed tests. While ACLA President Alan Mertz appreciates Shuren's willingness to engage, his group continues to push back hard against the agency's plan to move forward with a final LDT plan before Congress has a chance to act.

The commercial clinical lab industry says FDA should hold off from finalizing a guidance to actively regulate laboratory developed tests until Congress has had the chance to introduce legislation on the topic.

Alan Mertz, president of the American Clinical Laboratory Association, says while he appreciates that Center for Devices and Radiological Health Director Jeff Shuren spoke directly to ACLA member companies during...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation